Theme: Vaccines for the 21st century

Vaccines Asia Pacific-2016

Vaccines Asia Pacific-2016

Conference Series LLC invites all the participants from all over the world to attend '12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination' during November 24-25, 2016 in Melbourne, Australia which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Following the great success of the 5th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, July 27-28, 2015 Brisbane, Australia, Conference Series LLC is organizing the 12th Asia Pacific Global Summit and Expo on Vaccines Vaccination which is going to be held in Melbourne, Australia in 2016. This will be the latest in the Conference Series LLC annual vaccine meetings series with 500 Plus Attendees, to provide a forum where key vaccine stakeholders including academic researchers, public health clinicians, veterinarians, vaccine policy makers, Vaccine Research Development and manufacturers, Vaccine Business, Immunological Research and Vaccine Value Chain community, People focused on Immunoinformatics and Vaccines and Vaccine Informatics with the following profession areas: Innovators, Disruptors, and Influencers can exchange ideas and collaborate. There will be opportunities for those chosen to present at the meeting to publish a manuscript based on their presentation in the Journal of Vaccines & Vaccination or its sister publication, Immunome Research. Conference Series LLC organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Track 1: Vaccines against Infectious diseases

New Vaccine techniques like in vitro gene-manipulation have opened up new approaches to vaccine development. This has rapidly grown into an exciting area of Vaccines against infectious diseases research in both academic and industrial laboratories. There are a number of scientific challenges which require multidisciplinary teams to solve problems in developing new immunogens. This has challenged our existing knowledge about protein structure and conformation, microbial pathogenicity and the immune system. Recombinant-DNA techniques are invaluable as tools of analysis and antigen production. The surface of micro-organisms can also be minutely explored with the use of synthetic peptides and monoclonal antibodies. Nevertheless, these new technologies do not allow us to circumvent the need for detailed understanding of pathogens and the disease process. A lot of researches are going on Vaccines Immunology improving/developing new vaccines and administration of vaccines

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands.

Track 2:  Cancer Vaccines

Mainly Cancer vaccines are two types preventive and therapeutic. Cancer preventive vaccines target infectious agents that cause or contribute to the development of cancer. They are similar to traditional vaccines, which help prevent infectious diseases. Polio Vaccines by protecting the body against polio. Both cancer preventive Vaccine and traditional vaccines are based on antigens that are carried by infectious agents and that are relatively easy for the immune system to recognize as foreign.

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands.Next Generation Sequencing Research to Clinic California, United States;  The 4th International Veterinary Poultry Congress Exhibition of Iran Tehran, Iran

Track 3: Hepatitis Vaccines

Viruses that primarily attack the liver are called hepatitis viruses. There are several types of hepatitis viruses including types A, B, C, D, E, and possibly G. Types A, B, and C are the most mundane. Viral Hepatitis B virus infection and C can cause chronic hepatitis. Vaccination for hepatitis makes the immune system to protect from hepatitis viruses.

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands; 2nd Annual Biologics World Taiwan Taipei, Taiwan;  Next Generation Sequencing Research to Clinic California, United States;  The 4th International Veterinary Poultry Congress Exhibition of Iran Tehran, Iran

Track 4: Bacterial Vaccines

Vaccine  for antigenic substance prepared from the causative agent of a disease or a synthetic substitute, used to provide immunity against one or several diseases. Vaccination is one of the greatest breakthroughs in modern medicine. No other medical intervention has done more to save lives and improve quality of life. Bacterial vaccines contain killed or attenuated bacteria that activate the immune response. Antibodies are built against that particular bacteria, and prevents bacterial infection later. An example of bacterial vaccines is the Tuberculosis Vaccines

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands.Next Generation Sequencing Research to Clinic California, United States;  The 4th International Veterinary Poultry Congress Exhibition of Iran Tehran, Iran; BIT's 6th Annual World Congress of Vaccine Dalian, China

Track 5: DNA Vaccines

Genetic/ DNA immunization is a novel technique used to efficiently stimulate humoral and cellular immune response to protein antigens. The direct injection of genetic material into a living host causes a small amount of its cells to produce the introduced gene products. This inappropriate gene expression within the host has important Immunological Abnormalities, resulting in the specific immune activation of the host against the gene delivered antigen

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands.

Track 6: Combination Vaccines

The Number of Immunizations recommended is dramatically increasing day by day, especially for Childhood Vaccines United States the recommended immunization schedules for 2010 indicate that in the first 2 years children are expected to receive vaccines against 14 diseases. These combination Vaccine Adjuvants will deliver multiple vaccines in single visit/administration. Some of the combination vaccines are DTaP (DT) Vaccines, Tdap Vaccines etc.

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands, Next Generation Sequencing Research to Clinic California, United States

Track 7: Edible vaccines

Edible vaccines and Recombinant Vector Vaccines mostly useful as these are easy-to-administer, cost-effective, Less Storage problems, and easily acceptable vaccine delivery system, especially for the poor or developing countries. It involves introduction of selected desired genes into plants and then inducing these altered plants to manufacture the encoded proteins. Introduced as a concept about a decade ago, it has become a reality today. A variety of delivery systems have been developed. Initially thought to be useful only for preventing infectious diseases, it has also found application in prevention of Autoimmunity related diseases, birth control, cancer therapy, etc.

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands,  ITOC-1 Immunotherapy of Cancer Conference Munich, Germany

Track 8: Viral vaccines

Viral vaccines contain either inactivated viruses or attenuated (alive but not capable of causing disease) viruses. Inactivated or killed viral vaccines contain viruses, which have lost their ability to replicate and in order for it to bring about a response it contains more antigen than live vaccines. Viral Immunology Attenuated or live vaccines contain the live form of the virus. These viruses are not pathogenic but are able to induce an immune response.

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands.

Track 9: Vaccines against Vector borne Diseases

Mosquitoes, blackflies, sandflies, ticks, and lice are effective vectors of disease, transmitting pathogens via their blood meals. These Neglected Tropical Diseases (NTDs), are mostly diseases of poverty, and responsible for major economic burdens through disability, death of principal earners and missed educational opportunities for children and young adults, helping to maintain the poverty trap. It is no coincidence that the countries most affected by these diseases are also amongst the poorest countries in the world. Malaria is the most serious and costly of the insect-borne diseases with over 200 million cases of people being sick, and currently causing about 660,00 deaths per year, mostly children under the age of 5. The tragedy is that all these deaths could be stopped with a determined and coordinated approach.

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands. ITOC-1 Immunotherapy of Cancer Conference Munich, Germany; 2nd Annual Biologics World Taiwan Taipei, Taiwan

Track 10: Travel Vaccines

The measles-mumps-rubella (MMR) vaccine is very important for travelers.  Each year, unvaccinated people get measles while in other countries and bring it to the United States. This has sometimes led to outbreaks.  Since 2000, when measles was declared eliminated from the U.S., the annual number of people reported to have measles ranged from a low of 37 people in 2004 to a high of 668 people in 2014. The majority of measles cases brought into the U.S. come from U.S. residents. When we can identify vaccine status, almost all are unvaccinated. However, it may not just be MMR vaccine that you need.  You may be exposed to different diseases based on the countries you are visiting.  For example, you may need the yellow fever vaccine if traveling to certain countries in Africa or Central or South America.  If traveling to Asia, Latin America, or Africa, you may need typhoid vaccine.

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands.

Track 11: Mosquito-borne Diseases-Vaccines

Mosquito borne infectious diseases are among important group of diseases worldwide. Vaccination is available for some tropical mosquito-borne diseases, especially for Japanese encephalitis virus infection and yellow fever. There are also several attempts to develop new vaccines for the other mosquito-borne diseases such as malaria, dengue infection and West Nile virus infection.

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands. Immunization Summit 21-22 June 2016 Charleston Netherlands

Track 12Protein Based Vaccines

Protein based subunit vaccines present an antigen to the immune system without viral particles, using a specific, isolated protein of the pathogen. A weakness of this technique is that isolated proteins, if denatured, may bind to different antibodies than the protein of the pathogen. Commonly used protein-based subunit vaccines.

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands. Vaccine World Summit India Hyderabad, India; Immunization Summit 21-22 June 2016 Charleston Netherlands

Track 13Toxoid Vaccines

Toxoid vaccines are made from a toxin (poison) that has been made harmless but that elicits an immune response against the toxin. are based on the toxin produced by certain bacteria (e.g. tetanus or diphtheria). The toxin invades the bloodstream and is largely responsible for the symptoms of the disease. The protein-based toxin is rendered harmless and used as the antigen in the vaccine to elicit immunity. Many companies’ immunoinformatics help full in this regard to increase the immune response what are the best measures, the toxoid is adsorbed to aluminium or calcium salts, which serve as adjuvants.

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands, 10th Vaccine Congress 04-07 Sep Amsterdam

Track 14: Geriatric Immunization

Older adults are at increased risk for many vaccine-preventable diseases. Auto immunity is at low levels for older adults. Preventable illnesses cause substantial morbidity and mortality in older patients, who tend to have more medical co-morbidities and are at higher risk for complications. Acute respiratory infections, including pneumonia and influenza, are the 8th leading cause of death in the United States, accounting for 56,000 deaths annually. On average, influenza leads to more than 200,000 hospitalizations and 36,000 deaths each year (DHHS, Healthy People 2020).

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands. Vaccine World Summit India Hyderabad, India; Immunization Summit 21-22 June 2016 Charleston Netherlands; 10th Vaccine Congress 04-07 Sep Amsterdam

Track 15: Immune mediated Diseases-Vaccines

Patients with immune-mediated inflammatory diseases (IMID) such as RA, IBD or psoriasis, are at increased risk of infection, partially because of the disease itself, but mostly because of treatment with immunomodulatory or immunosuppressive drugs. In spite of their elevated risk for vaccine-preventable disease, vaccination coverage in IMID patients is surprisingly low. This review summarizes current literature data on vaccine safety and efficacy in IMID patients treated with immunosuppressive or immunomodulatory drugs and formulates best-practice recommendations on vaccination in this population. Especially in the current era of biological therapies, including TNF-blocking agents, special consideration should be given to vaccination strategies in IMID patients. Clinical evidence indicates that immunization of IMID patients does not increase clinical or laboratory parameters of disease activity. Live vaccines are contraindicated in immunocompromized individuals, but non-live vaccines can safely be given. Although the reduced quality of the immune response in patients under immunotherapy may have a negative impact on vaccination efficacy in this population, adequate humoral response to vaccination in IMID patients has been demonstrated for hepatitis B, influenza and pneumococcal vaccination. Vaccination status is best checked and updated before the start of immunomodulatory therapy: live vaccines are not contraindicated at that time and inactivated vaccines elicit an optimal immune response in immunocompetent individuals.

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands.; World Vaccines Congress Asia 03-04 June 2016 Singapore

Track 16: Innovative Development of Vaccines

New technological advances have accelerated vaccine research and development (R&D) yielding numerous vaccines that have significantly reduced mortality and morbidity. In fact, each year, vaccines prevent up to 2.5 million child deaths. But a number of diseases still lack an effective means of prevention; some, like HIV and AIDS, are caused by complex viruses that despite significant progress to-date, have proven to be evasive of existing vaccine technologies. With the emergence and expansion of new diseases, the need and demand for innovative vaccines continues to grow. But vaccine development is a complex, arduous, and expensive process. It requires a mastery of multiple technologies, ample funds for clinical trials and manufacturing facilities, sophisticated scale-up processes, expertise in navigating demanding regulatory environments in various regions, and managing vigorous safety monitoring. The R&D-based vaccine industry’s knowledge and capacity make it well-positioned to develop and manufacture new vaccine candidates. While both public and private partners play vital roles in vaccine development, it is industry that generally drives and manages the overall process that results in the approval of a new Vaccine.

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands.

Track 17: Mucosal vaccines

Mucosal surfaces are enormous surface areas that are vulnerable to infection by pathogenic microorganisms. The adaptive immune system is designed to distinguish antigens, pathogens and vaccines that enter the body through mucosal surfaces from those that are introduced directly into tissues or the bloodstream by injection or injury. It is becoming increasingly clear that local mucosal immune responses are important for protection against disease: for example, auto immunity of mucosal antibodies against Vibrio cholera bacteria and cholera toxin are associated with resistance to cholera, department cellular immunology is very helpful in mucosal vaccines formulation

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands.

Track 18: Child hood and maternal vaccines

Auto immunity and Vaccines help make you immune to serious diseases without getting sick first. Without a vaccine, you must actually get a disease in order to become immune to the germ that causes it. Vaccines work best when they are given at certain ages. For example, children don't receive measles vaccine until they are at least one year old. If it is given earlier it might not work as well. The Centers for Disease Control and Prevention publishes a schedule for childhood vaccines, Adjuvants in Immunology is also plays an important role in vaccines formulation.

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands.; 10th Vaccine Congress 04-07 Sep Amsterdam; World Vaccines Congress Asia 03-04 June 2016 Singapore

Track 19: Vaccines for unconventional diseases

When vaccines are mentioned most people think of immunization/ Autoimmunity against childhood infectious diseases. However, in recent years the uses to which vaccines are being put has dramatically expanded beyond traditional infectious disease applications. Vaccines currently in preclinical and clinical development target prevention or treatment of a wide range of non-infectious diseases including cancer, allergy, asthma, diabetes, rheumatoid arthritis, lupus, hypertension, heart disease, obesity, Alzheimer’s disease, Parkison’s disease and even nicotine and cocaine addiction. For the most part such vaccines aim to induce neutralizing antibodies against foreign or self-antigens, thereby blocking their activity and ability to induce disease. This commentary reviews key clinical advances in the area of unconventional vaccines and identifies some of the key challenges that need to be overcome in order for unconventional vaccines and Immunomodulation research to move forward to medical and commercial success.

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands The 4th International Veterinary Poultry Congress Exhibition of Iran Tehran, Iran; BIT's 6th Annual World Congress of Vaccine Dalian, China; Next Generation Sequencing Research to Clinic California, United States;  ITOC-1 Immunotherapy of Cancer Conference Munich, Germany; 2nd Annual Biologics World Taiwan Taipei, Taiwan; Vaccine World Summit India Hyderabad, India; Immunization Summit 21-22 June 2016 Charleston Netherlands; 10th Vaccine Congress 04-07 Sep Amsterdam; World Vaccines Congress Asia 03-04 June 2016 Singapore

Track 20: Developing Conjugate Vaccines

A conjugate vaccine is created by covalently attaching a poor (polysaccharide) antigen to a carrier protein (preferably from the same microorganism), thereby conferring the immunological attributes/ Immunological Tolerance of the carrier to the attached antigen.

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands.

Track 21: Plant Derived Vaccines

Plants offer enormous potential as production platforms for vaccines and therapeutic proteins. Plant-derived vaccines, for example, present an alternative to conventional vaccines by facilitating safe and effective oral delivery through consumption of edible plant tissue. Many infectious diseases enter the body through mucosal surfaces such as the gut, and as a result, vaccines expressed in the form of edible plant tissues offer a select advantage. The plant tissues can protect the antigen as it passes through the digestive tract. Plants are capable of producing recombinant antigens that undergo similar posttranslational modifications as their mammalian-derived counterparts and in contrast to bacterial expression systems. Moreover, high yields of biopharmaceuticals can be obtained, depending on the specific plant production platform. After these purification steps, the cost of producing plant-derived proteins represents only a fraction of the cost of proteins produced from analogous mammalian cell culture systems.

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands.; 10th Vaccine Congress 04-07 Sep Amsterdam; World Vaccines Congress Asia 03-04 June 2016 Singapore

Track 22: Vaccines for Pregnant women and Neonates

There is a special CDC guidelines for the vaccines you need before, during, and after pregnancy. Some vaccines, such as the measles, mumps, rubella (MMR Vaccines) vaccine, should be given a month or more before pregnancy. You should get some vaccines, like Tdap (to protect against whooping cough), during pregnancy. Other vaccines, like the flu shot, can be given before or during pregnancy, depending on whether pregnant. It is safe for a woman to receive Human papilloma vaccines right after giving birth, even while she is breastfeeding. Be sure to discuss each vaccine with your health care professional before getting vaccinated.

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands.

Track 23: Animal Immunization

The major goals of veterinary vaccines and Preclinical Vaccine Studies are to improve the health and welfare of companion animals, increase production of livestock in a cost-effective manner, and prevent animal-to-human transmission from both domestic animals and wildlife. These diverse aims have led to different approaches to the development of veterinary vaccines from crude but effective whole-pathogen preparations to molecularly defined subunit vaccines, genetically engineered organisms or chimeras, vectored antigen formulations, and naked DNA injections. The final successful outcome of vaccine research and development is the generation of a product that will be available in the marketplace or that will be used in the field to achieve desired outcomes.

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands.

Track 24:  Vaccines Adjuvants

The goal of vaccination is the generation of a strong immune response to the administered antigen able to provide long-term protection against infection. To achieve this objective with killed as opposed to live attenuated vaccines, often requires the addition of an adjuvant. Adjuvants are compounds that enhance the specific immune response against co-inoculated antigens.

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands.

Track 25: Vaccines Industry

The renaissance in the vaccine market continues with strong growth and new prospects to continue to grow this part of the market, which now stands at about $25 billion. Immunological Research Once a commodity market with low margins, the vaccines on the market now include blockbusters and mega blockbusters. New candidates for vaccinating against cancers and HIV Vaccines Research & Development  are also projected to hit the magic milestone. The market is expected to return a compound annual growth rate of more than 8% through 2018, Evaluate Pharma projects, with some segments like adult vaccines showing even better.

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands.

Track 26: Vaccines Trials

Delivery of a vaccine in a programme such as Expanded Program on Immunization is the end result of years of discovery and development. Only a tiny percentage of candidate vaccines progress to licensing, making the costs of vaccine Research and Development extremely high. This fact also makes it essential to maintain a healthy product portfolio, with a range of vaccines at different stages in the pipeline.

Development of vaccines can be simplified into two broad stages:

Pre-clinical vaccines studies development is research carried out in lab assays and on animals.  It includes: Immuno Thereapeutics Clinical development is when the vaccine is first tested in humans. It covers four stages over several years, from initial clinical trials in humans (phase I) right through to introduction and beyond (phase IV). Clinical development is built on rigorous ethical principles of informed consent from volunteers, with an emphasis on vaccine safety as well as efficacy.

Phase I clinical trials are small-scale trials to assess whether the vaccine is safe in humans and what immune response it evokes. For diseases of poverty this covers trials in European volunteers (phase Ia) and then in populations in Developing Countries (phase Ib).

Phase II clinical trials are larger and look mainly to assess the efficacy of the vaccine against artificial infection and clinical disease. Vaccine safety, side-effects and the immune response are also studied.

Vaccines that progress to phase III clinical trials are studied on a large scale of many hundreds of subjects across several sites to evaluate efficacy under natural disease conditions. If the vaccine retains safety and efficacy over a defined period, the manufacturer is able to apply to the regulatory authorities for a licence to market the product for human use.

The final phase IV happens after the vaccine has been licensed and introduced into use. Also called post-marketing surveillance, this stage aims to detect rare adverse effects as well as to assess long term efficacy.

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands.

Track 27: Vaccines Delivery Techniques

Currently excruciating research activity aimed at the development of incipient distribution systems for vaccines. The goal is to identify optimal methods for presenting target antigens to the Adaptive immunity in a manner that will elicit immune replications congruous for aegis against, or treatment of, a categorical disease. Several different approaches to this general goal have been developed, some are empirical and remain poorly understood, and others are more rational, being predicated, for example, on mimicking natural infections in vivo or on targeting particular features of the immune system. This article will review three categories of distribution systems: adjuvants and formulations;  antigen vectors, including live attenuated micro-organisms and synthetic vectors;  and novel contrivances for vaccine administration.

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands.

Track 28: Formulation

The renaissance in the vaccine market continues with strong growth and new prospects to continue to grow this part of the market, which now stands at about $25 billion. Once a commodity market with low margins, the vaccines on the market now include blockbusters and mega blockbusters. New candidates for vaccinating against cancers and HIV are also projected to hit the magic milestone. The market is expected to return a compound annual growth rate of more than 8% through 2018, Evaluate Pharma projects, with some segments like adult vaccines showing even better.

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands.

Track 29: Vaccines Business Development

Vaccines Business development: comprise a number of tasks and processes generally aiming at developing and implementing growth opportunities within and between organizations. It is a subset of the fields of business, commerce and organizational theory.

Related Vaccines Conferences | World Vaccine Congress | Vaccines Events | Conference Series LLC:

10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands.

Conference Series LLC Conferences invites all the participants from all over the world to attend '12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination' during November 24-26, 2016 in Melbourne, Australia which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Following the great success of the 5th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, July 27-28, 2015 Brisbane, Australia, Conference Series LLC is organizing the 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination which is going to be held in Melbourne, Australia in 2016. This will be the latest in the Conference series LLC annual vaccine meeting series with 500 Plus Attendees, to provide a forum where key vaccine stakeholders including academic researchers, public health clinicians, veterinarians, vaccine policy makers, and manufacturers can exchange ideas and collaborate. There will be opportunities for those chosen to present at the meeting to publish a manuscript based on their presentation in the Journal of Vaccines & Vaccination or its sister publication, Immunome Research. Conference Series LLC organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

 

Why to attend???

With members from around the world focused on learning about Vaccinology/Immunology and its advances; this is your best opportunity to reach the largest assemblage of participants from the Immunology/Vaccinology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new vaccines developments, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Immunology/Vaccinology are hallmarks of this conference.

Target Audience:

  • Vaccinology/Immunology Students, Scientists
  • Vaccinology/Immunology Researchers
  • Vaccinology/Immunology Faculty
  • Medical Colleges
  • Vaccinology/Immunology Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Software developing companies
  • Manufacturing Medical Devices Companies
  • Data Management Companies
  • Machinery Manufacturing Companies

- See more at: http://vaccines.global-summit.com/asia-pacific/index.php

 

 

The Asia Pacific Global Summit and Expo on Vaccines & Vaccination to be held at Melbourne, Australia during November 24-26, 2016 hosted by Conference series LLC Conferences through the theme "Discover and exploit emerging trends in vaccines and vaccination", conference will explore the advances in Vaccines and vaccination. This conference could be an exceptional event that brings along a novel and International mixture of giant and medium cognizance on vaccines and vaccination, leading universities engendering the conference an ideal platform to apportion expertise, foster collaborations across trade and world, and assess elevating technologies across the world. We Publish 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members and Organizes 300+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific societies.

Vaccination is a key to eradicate the diseases. It is a subject for the professionals who looks beyond the clinical prospects. Vaccines Asia Pacific-2016 amasses all the extroverts under one roof of current advances.

For more details please visit- http://vaccines.global-summit.com/asia-pacific/

      Vaccinology is a major field in eradication of diseases. Traditional approaches to vaccine design were to emasculate or inactivate the human pathogen or a cognate animal homologue, Vaccinology is the science of vaccine development and how the immune system responds to vaccines, but additionally includes perpetual evaluation of immunization programs and vaccine safety and efficacy, as well as surveillance of the epidemiology of vaccine-preventable diseases. This chapter provides a brief overview of some of the main concepts of immunology and vaccinology as they relate to immunization.

Why Melbourne? 

      In 2014 there are 20 vaccines and related conferences are held in australia. From thar three are from Melbourne.

Melbourne City Council provides a free immunisation service for children to help protect them against childhood diseases such as measles, whooping cough, polio and tetanus. Providing a free immunisation service is another way Council delivers towards the Melbourne Vision. Around 22 Biological giants are working in Australia. Around 15 top universities are working on vaccines research. In Australia.

Conference Highlights: 

·         Technologies for The Design, Discovery, Formulation and Administration of Vaccines

·         Developing Next-Gen Conjugate Vaccines

·         New Trends in Carbohydrate-based Vaccines

·         Vaccines for Pregnant Women

·         Recent Advances in Animal Vaccination

·         Adjuvants for Human Vaccines—Current Status, Problems and Future prospects

·         Current Developments in Bacterial Conjugate Vaccines Potency

·         Recent Trends in Attenuated Vaccines

·         Advancements in Vaccine Development

·         Vaccination and Quality of Life

Why to attend???

Vaccines Asia Pacific-2016 could be an event that brings along a novel and International mixture of giant and medium Vaccinology innovation and incipient trends in vaccines and vaccination, leading universities and vaccinology, vaccination research analysis establishments creating the conference an ideal platform to share expertise, foster collaborations across trade and world, and assess rising technologies across the world. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Vaccinology research are hallmarks of this conference.

A Unique Opportunity for Advertisers and Sponsors at this International event:

http://vaccines.global-summit.com/asia-pacific/Sponsorship.pdf

Major Vaccines Associations in & around Melbourne.

·         Vaccine research Association

·         Australian vaccination association

·         Australian medical association

·         Australian veterinary association

·         Association of veterinary vaccination

Major Vaccines Associations Globally

·         The International Society for Interferon and Cytokine Research

·         The International Society of Neuroimmunology

·         The International Union of Immunological Societies

·         The Society for Mucosal Immunology

·         The Society for Leukocyte Biology

·         Transplantation Society

·         British Society for Immunology

·         Cell Death Society

·         European Federation of Immunological Societies

·         European Society of Gene Therapy

·         Federation of African Immunological Societies

·         Federation of American Societies for Experimental Biology

·         Federation of Clinical Immunology Societies

·         Immune Deficiency Foundation

·         Infectious Diseases Society of America

Target Audience:

Vaccines Asia Pacific-2016 Targets, CEO’s , Directors, Scientists, Professors, Students of all Biotech & Pharma companies, Universities and colleges globally

Vaccines sales in global leader companies 2012(1st quarter):

·         Pfizer 2.2 B $

·         Sanofi  1.7 B $

·         Merck & Co 1.8 B $

·         GSK 2.5 B $

·         Novartis 0.44 B $

·         EBS 0.88 B $

In and Nearby Universities

·         Tulane University University of sydney

·         university of western australia

·         Griffith university

·         Bond university

Top Global Immunology Universities

 

   Rank          University Name

1              Harvard University

2              University of California--San Francisco

3              Stanford University

3              Yale University

5              Johns Hopkins University

5              Washington University in St. Louis

7              Duke University

7              University of Pennsylvania

9              University of Texas Southwestern Medical Center--DallasUniversity of California San Franciso

 

 http://www.university-list.net/us/rank/univ-1039.htm

Companies Associated with Vaccines

 

·         CareDx

·         Atara

·         Biotherapeutics

·         Benitec Limited  

·         InterMune

·         Biotron Limited

·         BioDiem

·         Antisense Therapeutics Limited           

·         GlaxoSmithKline Australia Pty Ltd

·         Bionomics

·         Australian Pharmaceutical Industries (API)   

·         BioPharmica Limited

Market Analysis of Vaccines

Tripled in value from USD 5B in 2000 to almost USD 24 B in 2013, Global market projected to rise to USD 100 B by 2025. More than 120 new products in the development pipeline. 60 are of importance for developing countries. UNICEF had a market of 1,03 B$ in 2011, PAHO had 400 million dollars in 2011 and total UN market of 340 million dollars in 2002,  1,430 billion dollars in 2011.

 

Overall Statasticks

Vaccines Asia Pacific-2015

            Sensing the raising importance of Vaccines, OMICS International hosted the 5th Asiapacific Global Summit and Expo on Vaccines & Vaccination” (Vaccines Asiapacific-2015), scheduled from July 27-29, 2015 in Brisbane, Australia with a theme “Vaccine Research: From Bench to Bedside”.  Benevolent response and active participation was received from the Editorial Board Members of OMICS Group Journals as well as from the Vaccines project managers, Vaccinologists, Immunologists, Vaccine researchers, scientists, doctors, students and leaders from the fields of Vaccines and Vaccination, Immunology, who made this event successful.

The meeting was carried out through various sessions, in which the discussions were held on the following thought provoking and cerebrating scientific tracks:

  • Technologies for the Design, Discovery, formulation and administration of vaccines.
  • Developing Next-Gen Conjugate Vaccines.
  • New trends in carbohydrate-based vaccines.
  • Vaccines for Pregnant Women.
  • Recent advances in animal vaccination
  • Adjuvants for human vaccines—current status, problems and future prospects.
  • Current developments in bacterial conjugate vaccines potency.
  • Recent trends in attenuated vaccines.
  • Advancements in vaccine development
  • Vaccination and quality of life
  • Protein subunits- vaccination.
  • Toxoid vaccines and its importance
  • Geriatric Immunization
  • Vaccines under research and development, major diseases
  • Innovative development of vaccines

The conference was embarked with an opening ceremony followed by workshop and a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were;

Dr. Nikolai Petrovsky, Flinders University, Australia

Dr. Roy Hall, The University of Queensland, Australia

Dr. Jan Fohlman, Växjö and Uppsala University, Sweden

Dr. Istvan Toth, The University of Queensland, Australia

Young Researchers:

Towards the development of oral vaccine delivery systems for lipid core peptide-based vaccines using novel multi-layer engineered nanoliposomes against Group A streptococcus

Nirmal Marasini, The University of Queensland, Australia

Title: A Protective Immune Response Using Asymmetric Multi-Epitope Self-Adjuvanting lipopeptide Vaccine Model

Sharareh Eskandari, The University of Queensland, Australia

Title: Binding and immune modulation properties of mannosylated lipo-peptide vaccines

Bita Sedaghat, The University of Queensland, Australia

Title: Liposomes as a Delivery Platform of Vaccines Against Group A Streptoccocus

Khairunnisa Abdul Ghaffar, University of Queensland, Australia

           Conference Series LLC offers its heartfelt appreciation to Societies and Organizations, Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who interlaced with Conference Series LLC in supporting and making the conference as never before one.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Vaccines Asiapacific-2015, Conference Series LLC is delighted to announce the next event.  Mark your calendars for the upcoming extravaganza," 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination" to be held during October 17-19, 2016 Kuala Lumpur, Malaysia.

Keynote Forum

Tracks

Posters&Accepted Abstracts

 For More details: http://vaccines.global-summit.com/asia-pacific/2015/

 

Vaccines 2014 report

The 4th International Conference on Vaccines & Vaccination, hosted by the Conference Series LLC. It was held in September 24-26, 2014 Valencia, Spain. Generous response and active participation was received from the Editorial Board Members of our Journals as well as from scientists, researchers and leaders from Pharma, government organizations, students who made this conference as one of most successful and productive events in 2014 from Conference Series LLC. Also, the conference was carried out through various sessions, in which the discussions were held on the following scientific tracks:

Overview

http://www.conferenceseries.com/immunology-conferences.php

• Vaccines and the Basic Immune System

• New Approaches for B and T Cells

• Cellular and Molecular-Based Vaccines

• Vaccines Against Infectious Diseases

• Manufacturing, Production and Development of Vaccines

• Regulatory and Ethical Issues of Vaccines and Public Acceptance

• Current Issues on Clinical Evaluation and Field Trials of Vaccines

• Modern Technologies in Vaccine Discovery and Development

• Age-Specific Immune Response to Vaccination

• Novel Delivery technologies in Vaccines and many more...

The response to 4th International Conference on Vaccines & Vaccination was huge and was attended by about 550 attendees representing 55 countries from different corners of the world. The conference was initiated with a series of invited lectures delivered by both Honorable Guests and members of the keynote forum. The list included

Jeffrey B Ulmer, Novartis Vaccines USA

Ray Spier, Former President, International Society for Vaccines, UK

Michael G Hanna, CEO, Vaccinogen, Inc., USA and many more...

All the above mentioned Honorable Guests and keynote speakers gave their energetic and fruitful contributions at Vaccines-2014.

All accepted abstracts have been indexed in Our International -Journal of Vaccines & Vaccination as a special issue. The theme of this Conference was on “Prospects and Development of Prophylactic & Therapeutic Vaccines”. Based on this, speaker’s discussions included many recommendations.

Conference Proceedings

Keynote speakers

Scientific Tracks

Posters

Accepted Abstracts

Sponsors and exhibitors

Sanofi Pasteur SA

U.S. Headquarters, Discovery Drive, Swiftwater, PA 18370

Vaccinogen Inc.,

5300 West view Dr # 406, Frederick, MD 21703, United States

Cellular Technology Limited (CTL)

North & South America

CTL Headquarters, 20521 Chagrin Blvd., Shaker Heights, OH 44122-5350 USA,

Gen Phar

600 Seacoast Pkwy # 100,

Mt Pleasant, SC 29464, United States

 

Vaccines-2013 Report

Conference Series LLC, the global leader in organizing annual “International conferences and Exhibitions on Vaccines and Vaccinations” The Annual Vaccines Conferences provides high-quality, current reports of scientific progress and best practices featured in both invited presentations and submitted oral abstracts and posters. The Global Vaccines Conferences and Expos organized by Conference Series LLC, bring together the diverse disciplines involved in the research and development of vaccines and associated technologies for disease control through immunization. By drawing upon an global audience of CEOs, CSOs, scientists and researchers, healthcare professionals and trainees, veterinarians, vaccine manufacturers, and public health officials, the conference is designed to encourage the exchange of ideas across a broad range of disciplines.

 Highlights of Annual Global Vaccines Conferences- Conference Series LLC

 • Keynote forum

• Exhibitions

• Company Presentations

• Speaker Forum

• Workshops and Symposia’s

• B2B Meetings

• One to One meeting

• Special Session for Students

• Scientific writing

• Journal review

• Grant writing

• Strategies for building a scientific career

• Scientific careers outside of research

• Company Promotions

• Young Research Forum

• Best Poster Awards

• Certification by the “International Organizing committee” and many more... 

 

Vaccines-2012 Report

The 2nd International Conference on Vaccines & Vaccination, hosted by the Conference Series LLC. It was held in August 20-22, 2012 in Hilton Chicago/Northbook, USA. Generous response and active participation was received from the Editorial Board Members of Conference Series LLC International Journals as well as from scientists, researchers and leaders from Pharma, government organizations, students who made this conference as one of most successful and productive events in 2012 from Conference Series LLC. Vaccines 2012 hosted 300+ attendees representing 55 countries from different corners of the world. The conference was carried out through various sessions, in which the discussions were held on the following

 Scientific tracks:

• Vaccines and the Basic Immune System

• New Approaches for B and T Cells

• Cellular and Molecular-Based Vaccines

• Vaccines Against Infectious Diseases

• Manufacturing, Production and Development of Vaccines

• Regulatory and Ethical Issues of Vaccines and Public Acceptance

• Current Issues on Clinical Evaluation and Field Trials of Vaccines

• Modern Technologies in Vaccine Discovery and Development

• Age-Specific Immune Response to Vaccination and many more...

 Conference Proceedings

Keynote speakers

Scientific Tracks

Posters

Accepted Abstracts

The response to 2nd International Conference on Vaccines & Vaccination was huge and was attended by about 300 attendies representing 25 countries from different corners of the world. The conference was initiated with a series of invited lectures delivered by both Honorable Guests and members of the keynote forum. The list included

 De-Chu Christopher Vaxin Inc., USA

John Dong GenPhar, USA

Donald E. Greydanus Western Michigan University School of Medicine, USA

Eli Young OpSaniTx, USA

Takashi Kei Kishimoto Selecta Biosciences, USA

Daniel H Zimmerman CEL-SCI Corporation, USA

Gerardo Kaplan FDA, USA

Kei Amemiya U.S. Army Medical Research Institute of Infectious Diseases, USA

Haval Shirwan University of Louisville, USA and many more.

All the above mentioned Honorable Guests and keynote speakers gave their energetic and fruitful contributions at Vaccines-2012.All accepted abstracts have been indexed in our- Journal of Vaccines & Vaccination as a special issue. The theme of this Conference was on “Prospects and Development of Prophylactic & Therapeutic Vaccines”. Based on this, speaker’s discussions included many recommendations.

 

 Vaccines-2011 Conference Report

The International Conference and Exhibition on Vaccines & Vaccination (Vaccines-2011) was held on November

22-24, 2011 in Philadelphia Airport Marriott Hotel, USA. This successful conference organized by Conference Series LLC brought together Medical Specialists, Researchers and Vaccine Developers who were delighted with the many speeches, presentations, and discussions, which demonstrated the determination to innovate and improve knowledge on Vaccines.Vaccines-2011, helped to open new ideas, advanced technologies, innovative approaches towards Vaccines. Several speakers from almost 30 countries have participated in this conference which was carried out through several sessions with the theme “Current Strategies in Vaccination”.

Conference highlighted the following topics:

• Vaccines and the basic immune system

• New approaches for B and T cells

• Cellular and molecular-based vaccines

• Vaccines against infectious diseases

• Therapeutic vaccine manufacturing, production and development

• Logical and ethical issues and vaccines

• Experimental and clinical evaluation of therapeutic vaccines

• Basic Vaccinology and modern vaccine discovery technologies and many more...

The Luxurious accommodation during the conference also created a relaxed and informal atmosphere with

aright setting for highly interactive sessions where the speakers shared the knowledge on current issues and

strategies of Vaccines and Vaccination.

We take an immense pleasure in thanking our Keynote Speakers:

Gary Alan Flory Virginia Department of Environmental Quality, USA

Gregory J. Tobin Biological Mimetics, Inc. (BMI), USA

Kei Amemiya US Army Medical Research Institute, USA

Edmund J. Gosselin Albany Medical College, USA

Mansour Mohamadzadeh University of Florida, USA and many more...

Vaccines 2011 hosted 200+ attendees representing 30 countries from different corners of the world.

 Conference Proceedings

Keynote speakers

Scientific Tracks

Posters

Accepted Abstracts

We are grateful to all speakers, scientific societies, governmental and non-governmental institutions, Professors, scientists, representatives of patient groups from throughout the world for their commitment and the support. We would like to thank our organizing committee members for providing advice on the agenda, and in supporting the conference. We are grateful to NIH, GSK, Sanofi Pasture, and other sponsors for their invaluable support for the success of the event. Journal of Vaccines & Vaccination and Journal of Clinical & Cellular Immunology have published all papers presented at this meeting as a special issue. With the overwhelming response and suggestions and feedbacks from our previous attendees. Conference Series LLC is organizing its Global Vaccines conferences in major countries across the globe: We are also obliged to various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums. Our sincere thanks to Organizing Committee Members for their gracious presence, support and assistance towards Vaccines-2012.

 

 


Past Reports  Proceedings  Gallery  

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date November 24-25, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2 Day 3
Poster Opportunity Available

Media Partners

Conferenceseries Destinations


Mail us at

Drop us an email for Program enquiry.
vaccinesasiapacific@omicsgroup.com
Sponsors / Exhibiting / Advertising.
vaccines@conferenceseries.net
General Queries.

View Proceedings of Previous Conferences

Vaccines Asia Pacific 2015
Euro Vaccines 2015
Dubai Vaccines 2015
American Vaccines 2015
Authorization Policy

By registering for the conference you grant permission to Conferenceseries LLC to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or videotaping during any session is prohibited. Contact us for any queries.